viruses
Article
Cross-Reaction or Co-Infection? Serological Discrimination of
Antibodies Directed against Dugbe and Crimean-Congo
Hemorrhagic Fever Orthonairovirus in Nigerian Cattle
Julia Hartlaub 1,† , Oluwafemi B. Daodu 2,† , Balal Sadeghi 1 , Markus Keller 1 , James Olopade 3 ,
Daniel Oluwayelu 4 and Martin H. Groschup 1, *
1
2
3
4
*
†
Citation: Hartlaub, J.; Daodu, O.B.;
Sadeghi, B.; Keller, M.; Olopade, J.;
Oluwayelu, D.; Groschup, M.H.
Cross-Reaction or Co-Infection?
Serological Discrimination of
Antibodies Directed against Dugbe
and Crimean-Congo Hemorrhagic
Fever Orthonairovirus in Nigerian
Cattle. Viruses 2021, 13, 1398.
https://doi.org/10.3390/v13071398
Academic Editor: Bas B.
Oude Munnink
Received: 24 June 2021
Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Suedufer 10,
17489 Greifswald–Insel Riems, Germany; julia.hartlaub@fli.de (J.H.); balal.sadeghi@fli.de (B.S.);
markus.keller@fli.de (M.K.)
Department of Veterinary Microbiology, University of Ilorin, Ilorin 240103, Nigeria;
daodu.ob@unilorin.edu.ng
Department of Veterinary Anatomy, University of Ibadan, Ibadan 200284, Nigeria;
jkayodeolopade@yahoo.com
Department of Veterinary Microbiology, University of Ibadan, Ibadan 200281, Nigeria; ogloryus@yahoo.com
Correspondence: martin.groschup@fli.de; Tel.: +49-38351-7-1163
These authors contributed equally to this work.
Abstract: Dugbe orthonairovirus (DUGV) and Crimean-Congo hemorrhagic fever orthonairovirus
(CCHFV) are tick-borne arboviruses within the order Bunyavirales. Both viruses are endemic in
several African countries and can induce mild (DUGV, BSL 3) or fatal (CCHFV, BSL 4) disease
in humans. Ruminants play a major role in their natural transmission cycle. Therefore, they are
considered as suitable indicator animals for serological monitoring studies to assess the risk for human
infections. Although both viruses do not actually belong to the same serogroup, cross-reactivities
have already been reported earlier—hence, the correct serological discrimination of DUGV and
CCHFV antibodies is crucial. In this study, 300 Nigerian cattle sera (150 CCHFV seropositive and
seronegative samples, respectively) were screened for DUGV antibodies via N protein-based ELISA,
indirect immunofluorescence (iIFA) and neutralization assays. Whereas no correlation between
the CCHFV antibody status and DUGV seroprevalence data could be demonstrated with a newly
established DUGV ELISA, significant cross-reactivities were observed in an immunofluorescence
assay. Moreover, DUGV seropositive samples did also cross-react in a species-adapted commercial
CCHFV iIFA. Therefore, ELISAs seem to be able to reliably differentiate between DUGV and CCHFV
antibodies and should preferentially be used for monitoring studies. Positive iIFA results should
always be confirmed by ELISAs.
Accepted: 15 July 2021
Published: 19 July 2021
Publisher’s Note: MDPI stays neutral
Keywords: DUGV; Dugbe orthonairovirus; CCHFV; Crimean-Congo hemorrhagic fever orthonairovirus;
Nigeria; serology; cattle; specificity; sensitivity; cross-reactivity
with regard to jurisdictional claims in
published maps and institutional affiliations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1. Introduction
Dugbe orthonairovirus (DUGV) is a zoonotic, tick-borne arbovirus (order Bunyavirales), which occurs widespread throughout Africa. In 1964, it was first isolated in Nigeria
out of a pool of Amblyomma variegatum ticks [1]. Most of the isolates were obtained from
ticks, but several strains have also been isolated from animals (cattle, wild rodents) and
humans [1–4]. Ruminants seem to play a major role in the infection cycle, as most of
the DUGV-positive ticks were collected from sheep, goats and cattle. Actually, DUGV is
thought to be the most frequently isolated arbovirus in Nigeria [5]. However, all serological and virological investigations conducted on the virus occurred between 1964 and
1977 [1,6–8], and therefore, DUGV is quite a neglected virus in Nigeria nowadays. This
might probably be due to its limited impact on animal and human health. No overt diseases
Viruses 2021, 13, 1398. https://doi.org/10.3390/v13071398
https://www.mdpi.com/journal/viruses
Viruses 2021, 13, 1398
2 of 13
have been observed in livestock, and reports of human infections, resulting in mild febrile
illnesses, are scarce [1,3,4]. Hence, the influence on the public health and economic sector
is rather low, and therefore, no increased awareness towards this arbovirus exists.
However, DUGV might still be of significant importance, as a distant serological
relationship to Crimean-Congo hemorrhagic fever orthonairovirus (CCHFV) is presumed.
Although these viruses do not belong to the same serogroup, several studies have revealed
serological cross-reactivities [9,10]. Sequence analyses have shown 43% and 16% amino
acid differences between CCHFV and DUGV for the complete sequence of the S segment
and partial genome sequences of the L segment, respectively [11,12]. In contrast to DUGV,
the public health impact of CCHFV is not negotiable. Causing severe hemorrhagic fever
with case fatality rates of 5–30% in humans, CCHFV is on the WHO R&D list of blueprint
priority diseases [13]. To elucidate the current distribution of this BSL 4 agent and to assess
the risk for human infections, serological monitoring studies involving ruminants are being
conducted worldwide [14]. Due to their genetic and antigenic relationship, concerns arise
that antibodies directed against DUGV might interfere with current CCHFV serological
assays. If these antibodies led to false-positive CCHFV test results, the distribution and
prevalence of CCHFV would be rather overestimated in regions where DUGV is also
prevalent. In fact, Nigeria is a suitable representative for an African country, where
both viruses co-exist. Recent studies have revealed CCHFV seroprevalence in Nigerian
cattle (24% of 50 bovines) and CCHFV-IgG antibodies (10.6% of 1189 sera) in Nigerians,
respectively [15,16]. In 2016, the first published CCHFV case diagnosed by RT-qPCR was
reported [16].
Whereas in former studies, methods such as hemagglutination inhibition (HI) and
complement fixation (CF) were utilized [9], only a few recent studies exist where ELISAs
were employed to investigate putative cross-reactivities. Two studies were conducted in
Africa to search for DUGV and CCHFV antibodies in cattle. Formalin or β-propiolactone
inactivated virus stocks were coated on ELISA plates, and prevalence data for DUGV and
CCHFV antibodies were compared. However, the obtained results were quite contradictory:
whereas the authors from the study in the Central African Republic reported that 96% of
the tested cattle sera with antibodies against CCHFV also reacted with the DUGV antigen,
a study from South Africa revealed that only 7% of sera with CCHFV-reactive antibodies
did also bind to the DUGV antigen [17,18]. Moreover, even if recombinant proteins were
utilized, which are thought to be more specific than inactivated whole virus antigens, slight
cross-reactivities were observed when the DUGV N protein was challenged with mono- or
poly-specific CCHFV antisera in Western Blots and ELISAs [19].
Recently performed studies with immunized and experimentally infected sheep and
cattle revealed that ruminants do not show any clinical signs nor develop viremia, detectable by RT-qPCR. However, a constant feature in both species was the generation of
DUGV specific antibodies [20]. In the course of this study, we have developed several assays for the detection of these antibodies, namely an indirect ELISA based on recombinant
N protein, an indirect immunofluorescence assay (iIFA) and a micro-virus neutralization
test (mVNT). Furthermore, all serum samples were tested with currently used CCHFV
diagnostic assays (FLI CCHFV In-house ELISA, Vector-Best ELISA, IDVet double antigen
ELISA, Euroimmun iIFA) to investigate potential antibody cross-reactivities. Our data
indicate that CCHFV ELISA systems were able to discriminate between these antibodies,
whereas the immunofluorescence assay was not. However, these findings have to be
reassured when sera following natural infections are analyzed, as these might actually
yield higher levels of antibodies than artificially infected animals. Furthermore, only antibodies raised against one DUGV strain (IBAR1792) have been tested, but strain-specific
antibodies against different currently circulating DUGV strains could also have an impact
on cross-reactivities.
The aim of the presented work was to validate the new DUGV serological assays
utilizing sera from Nigerian cattle, including the determination of ELISA cut-off values, as
well as diagnostic specificities and sensitivities. We first pre-tested the sera for the presence
Viruses 2021, 13, 1398
3 of 13
of CCHFV antibodies with previously validated CCHFV serological assays. Out of this
serum panel, we subsequently selected 150 CCHFV clearly seropositive and 150 definite
seronegative samples, respectively, and analyzed them with our DUGV assays (ELISA,
iIFA, mVNT). Our main interest in this project was the comparison of both groups and to
evaluate whether the CCHFV antibody status has any influence on DUGV seroprevalence
data and vice versa.
In summary, serological assays for CCHFV (and DUGV) will serve solely as valuable
tools for monitoring programs conducted in countries where both related viruses are
endemic if antibodies to both viruses are reliably discriminated. The results obtained
within this study will hopefully contribute to a more profound and justified interpretation
of seroprevalence data in the fields of Orthonairoviruses in the future.
2. Materials and Methods
2.1. Sera: Collection and Selection
In 2018, cattle sera were collected from different local government areas in Kwara State,
North-Central Nigeria. Samples were taken at abattoirs and farms (nomadic and seminomadic settlements). All sera were sent to Friedrich-Loeffler-Institut, Greifswald-Insel
Riems, Germany for serological investigations. Before these analyses, samples were tested
for the presence of CCHFV RNA (RT-qPCR), and only negative samples were further used
for serological testing. Sera were first tested for the presence of CCHFV antibodies. For
the presented study, out of these sera, 150 CCHFV seropositive (positive in IDVet ELISA,
positive or doubtful in Vector-Best ELISA and FLI CCHFV In-house ELISA, respectively)
and 150 seronegative (negative in all 3 CCHFV ELISAs) samples were randomly selected.
2.2. DUGV Serological Assays
DUGV serological assays were performed as previously described [20].
1.
ELISA: The indirect ELISA is based on recombinant DUGV N protein (bacterially
expressed, DUGV strain ArD44313). After a blocking step, sera were added (1/20 dilution), and plates were incubated with an anti-bovine secondary antibody. The reaction
was induced by TMB and stopped with 1M H2 SO4 . Corrected OD450 values were
calculated (wells coated with antigen-wells without antigen), and the percentage of
the samples in comparison to the positive control (immunized cattle) was determined.
The nucleotide and amino acid sequence identities between the utilized DUGV strain
for N protein expression and other sequenced DUGV strains are presented in Table 1.
Table 1. N protein homologies of known DUGV strains.
Amino
acids
Nucleotides
ArD 44313
IbH 11480
IbAr 1792
ArD 44313
X
99.04%
99.24%
IbH 11480
99.59%
X
99.52%
IbAr 1792
99.79%
99.79%
X
(analysis: available GenBank sequences, calculation performed by Geneious).
2.
3.
iIFA: The indirect immunofluorescence assay is based on DUGV (IBAR1792) infected
Vero E6 cells and non-infected control wells. After a blocking step, all sera (1/50
diluted) were incubated before the secondary antibody was added, and the fluorescence signal was evaluated. Sera were scored positive if a specific staining of DUGV
infected cells was visible without non-specific compounds against non-infected Vero
E6 cells.
mVNT: The micro-virus neutralization test was performed on SW13 cell monolayers
in a 96-well format. Serial serum dilutions were incubated with 100 TCID50 DUGV
(IBAR1792) and then transferred in duplicates to the prepared SW13 plates. Plates
Viruses 2021, 13, 1398
4 of 13
were stained with crystal violet after 7 days, and the cytopathic effect was evaluated.
Neutralizing titers were calculated according to Behrens and Kaerber. Sera with titers
≥ 1/10 were scored positive.
2.3. CCHFV Serological Assays
1.
2.
3.
4.
IDVet double antigen ELISA (IDVet, Grables, France): This ELISA is based on recombinant CCHFV N protein (clade III) and was performed according to the manufacturers’
instructions. The percentage of the sample in comparison to the positive control was
calculated (S/P%). Sera >30% were scored positive.
Vector-Best ELISA (Novosibirsk, Russia): This ELISA is based on CCHFV whole
virus antigen (clade IV). A species-adapted protocol for bovines was performed as
described before [21]. Optical density (OD) values were determined. Sera with values
<0.3 and >0.5 were scored negative and positive, respectively. Doubtful results were
in between.
FLI CCHFV In-house ELISA: This ELISA is based on recombinant CCHFV N Protein
(clade V). A bovine-specific protocol was used [22]. The percentage of the sample in
comparison to the positive control was calculated (S/P%). Sera <16% were scored
negative and >19% positive. Doubtful results were in between.
Indirect immunofluorescence assay (Euroimmun, Luebeck, Germany): This assay is
based on cells expressing GPC (glycoprotein precursor) and N proteins of CCHFV
(clade III). A bovine-specific protocol was used [21]. Sera were scored positive if a
specific fluorescence signal was detected in comparison to the signal detected for
non-transfected cells.
2.4. Statistical Analysis
The area under the receiver operating characteristic (ROC) curve was used to determine the ELISA cut-off value. Sensitivity, specificity, positive predictive value (PPV) and
negative predictive value (NPV) were evaluated. Statistical analyses were performed using
MedCalc for Windows, version 19.4 (MedCalc Software, Ostend, Belgium). p-value < 0.05
was regarded as statistically significant.
The generalized linear model (GLM) was used for the determination of serological
cross-reactivity. The percent agreement between the two assays was calculated using
Pearson’s Chi-squared test. Statistical analysis was conducted with the SPSS software
version 22.0 for Windows (IBM Corp., New York, NY, USA). P-value < 0.05 was considered
statistically significant.
3. Results
No commercial DUGV serological diagnostic test, which could serve as a reference
standard for the evaluation of the newly developed assays, is currently available. However, neutralization assays are, in general, rated as highly specific and therefore, the
DUGV mVNT was set as a gold standard to validate the performance of the other assays
(ELISA, iIFA).
3.1. Establishment and Validation of Indirect DUGV IgG ELISA
All sera were tested with the DUGV ELISA, and receiver operating characteristic
(ROC) analysis was performed for the determination of the ELISA cut-off value in regards
to maximum sensitivity and specificity (Figure 1). The calculated cut-off (40.9%) led to a
specificity of 88.6% and a sensitivity of 95.7%. Figure 2 illustrates the relationship between
corrected OD values and mVNT titers for all 300 tested serum samples.
Viruses 2021, 13, x FOR PEER REVIEW
Viruses 2021, 13, x FOR PEER REVIEW
Viruses 2021, 13, 1398
5 of 13
5 of 13
to maximum sensitivity and specificity (Figure 1). The calculated cut-off (40.9%) led to a
to
maximum
specificity
(FigureFigure
1). The
calculatedthe
cut-off
(40.9%) between
led to a 5 of 13
specificity
of sensitivity
88.6% and aand
sensitivity
of 95.7%.
2 illustrates
relationship
specificity
and
a sensitivity
of 95.7%.
2 illustrates
the relationship between
corrected of
OD88.6%
values
and
mVNT titers
for all Figure
300 tested
serum samples.
corrected OD values and mVNT titers for all 300 tested serum samples.
Figure 1. ROC analysis employing 300 Nigerian cattle sera: Diagnostic sensitivity of the DUGV
ELISA
is
(95%
CI employing
91.7–98.1)
and
diagnostic
specificity
isDiagnostic
88.6%
(95%
CI 81.3–93.8)
with
AUC
Figure
ROC
300300
Nigerian
cattle
sera:sera:
sensitivity
of the
Figure 1.
1. 95.7%
ROCanalysis
analysis
employing
Nigerian
cattle
Diagnostic
sensitivity
ofDUGV
the
DUGV
being 0.951
(p-value
<CI0.001).
ELISA
is
95.7%
(95%
91.7–98.1)
and
diagnostic
specificity
is
88.6%
(95%
CI
81.3–93.8)
with
AUC
ELISA is 95.7% (95% CI 91.7–98.1) and diagnostic specificity is 88.6% (95% CI 81.3–93.8) with AUC
being 0.951 (p-value < 0.001).
being 0.951 (p-value < 0.001).
Figure 2.
and
corrected
ODOD
values:
onlyonly
8 sera
werewere
false-negative
(green(green
Figure
2. Correlation
CorrelationofofmVNT
mVNTtiters
titers
and
corrected
values:
8 sera
false-negative
triangles)
and 12
12 sera
sera
false-positive
(red
dots)
of
300
false-negative
sera
Figure
2. Correlation
offalse-positive
mVNT titers and
OD
onlycattle
8 serasera.
wereSix
false-negative
(green
triangles)
and
(redcorrected
dots) out
out
ofvalues:
300 tested
tested
cattle
sera.
Six
false-negative
sera and
and two false-positive
sera actually (red
yielded
CCHFV
with
triangles)
and 12 sera false-positive
dots)
out ofantibodies
300 tested(marked
cattle sera.
Six*).false-negative sera
two false-positive sera actually yielded CCHFV antibodies (marked with *).
and two false-positive sera actually yielded CCHFV antibodies (marked with *).
In order
order to
toevaluate
evaluatewhether
whether DUGV
DUGVand
andCCHFV
CCHFVantibodies
antibodiescross-react
cross-reactininthe
thecorreIn
In order to ELISAs,
evaluate 150
whether
and seropositive
CCHFV antibodies
in the
corresponding
clearlyDUGV
CCHFV
and 150cross-react
clearly CCHFV
sponding ELISAs, 150 clearly CCHFV seropositive and 150 clearly CCHFV seronegative
corresponding
ELISAs,
150 clearly
CCHFV seropositive
150 clearly
seronegative serum
samples
were pre-selected
and further and
analyzed
with theCCHFV
DUGV
serum samples were pre-selected and further analyzed with the DUGV mVNT and DUGV
seronegative
serum ELISA.
samplesFigure
were 3pre-selected
andcorrected
further analyzed
with
mVNT and DUGV
visualizes the
OD values
for the
bothDUGV
serum
ELISA. Figure 3 visualizes the corrected OD values for both serum groups. Table 2 shows
mVNT
DUGV
ELISA.
Figure 3 visualizes
the corrected
OD values
for both
serum
groups.and
Table
2 shows
the cross-tabulation
of DUGV
and CCHFV
data, and
Figure
4 the
the cross-tabulation of DUGV and CCHFV data, and Figure 4 the corresponding bar chart.
groups.
Table 2 bar
shows
the cross-tabulation of DUGV and CCHFV data, and Figure 4 the
corresponding
chart.
corresponding bar chart.
Viruses 2021, 13, 1398
Viruses 2021, 13, x FOR PEER REVIEW
6 of 13
Viruses 2021, 13, x FOR PEER REVIEW
6 of 13
6 of 13
Figure
OD
values
forfor
300300
Nigerian
cattle
sera:sera:
The The
distribution
patterns
between
Figure3.3.Corrected
Corrected
OD
values
Nigerian
cattle
distribution
patterns
between
CCHFV
seropositive
sera
(red
dots)
and
CCHFV
seronegative
sera
(green
dots)
do
not
apparently
Figure
3. seropositive
Corrected OD
values
300and
Nigerian
cattle
sera: The sera
distribution
patterns
between
CCHFV
sera
(red for
dots)
CCHFV
seronegative
(green dots)
do not
apparently
vary
between
each other.
CCHFV
seropositive
sera (red dots) and CCHFV seronegative sera (green dots) do not apparently
vary between each other.
vary between each other.
Table
table
ELISA
(CCHFV
× DUGV).
Table2.2.Cross-tabulation
Cross-tabulation
table
ELISA
(CCHFV
× DUGV).
Table 2. Cross-tabulation table ELISA (CCHFV × DUGV).
Neg
CCHFV
CCHFV
CCHFV
Neg
Pos
Pos
DUGV
DUGV
Neg DUGV Pos
Neg
Pos
Count
49
101
Neg
Pos
Count
49
101
% within
CCHFV
32.7%
67.3%
Count
49
101
Neg
% within CCHFV
32.7% 67.3%
Count
60
90 67.3%
% within
CCHFV
32.7%
Count
60
% within
CCHFV
40.0%
60.0%
Count
60
90 90
Pos
% within CCHFV
40.0% 40.0% 60.0%
% within CCHFV
60.0%
Total
Total
Total
150
150
100.0%
150
150100.0%
100.0%
100.0%
150 150
100.0%
100.0%
Figure 4. Cross-reactivity N protein-based ELISAs: The percentage of DUGV antibody-positive sera
is
slightly lower for the CCHFV
seropositive
samples,
of of
good
serological
discrimination
Figure
NN
protein-based
ELISAs:
Theindicative
percentage
DUGV
antibody-positive
sera sera
Figure4.4.Cross-reactivity
Cross-reactivity
protein-based
ELISAs:
The
percentage
of DUGV
antibody-positive
of
DUGV
and
CCHFV
antibodies
via
ELISA.
is slightly lower for the CCHFV seropositive samples, indicative of good serological discrimination
is slightly lower for the CCHFV seropositive samples, indicative of good serological discrimination
of DUGV
CCHFV antibodies
via ELISA.
Whenand
comparing
DUGV seroprevalence
data of CCHFV seropositive and CCHFV
of DUGV and CCHFV antibodies via ELISA.
seronegative
samples, it
seemsseroprevalence
that the CCHFV
status
has noseropositive
influence onand
theCCHFV
DUGV
When comparing
DUGV
data
of CCHFV
When comparing
DUGV
seroprevalence
data of samples
CCHFV revealed
seropositive
and CCHFV
seroprevalence.
Whereas
67%
of
CCHFV
seronegative
anti-DUGV
seronegative samples, it seems that the CCHFV status has no influence on the DUGV
seronegative
it seems
that thelower
CCHFV
status
has no influence on
the DUGV
antibodies,
thesamples,
percentage
wasofslightly
for the
CCHFV
samples
seroprevalence.
Whereas 67%
CCHFV seronegative
samples seropositive
revealed anti-DUGV
seroprevalence.
Whereas
67%
of
CCHFV
seronegative
samples
revealed
anti-DUGV
(60.0%).
If antibodies
directedwas
against
CCHFV
led to
results seropositive
in the DUGV samples
ELISAs, anantibodies,
the percentage
slightly
lower
forpositive
the CCHFV
tibodies,
the
percentage
was
slightly
lower
for
the
CCHFV
seropositive
samples
(60.0%).
the
fraction
of DUGV-positive
sera would
be led
significantly
sera
with positive
(60.0%).
If antibodies
directed against
CCHFV
to positivehigher
resultsfor
in the
DUGV
ELISAs,
If
antibodies
directed
against
CCHFV
led
to
positive
results
in
the
DUGV
ELISAs,
CCHFV
status,
and no or extremely
low numbers
of complete
DUGV
seronegative
sera the
the fraction
of DUGV-positive
sera would
be significantly
higher
for sera
with positive
fraction
of
DUGV-positive
sera
would
be
significantly
higher
for
sera
with
positive
CCHFV
would
expected.
CCHFVbestatus,
and no or extremely low numbers of complete DUGV seronegative sera
status,
and
no
or
extremely
low
numbers
of
complete
DUGV
seronegative
sera
ROC
analysis employing the CCHFV seronegative samples only revealed reducedwould
would
be expected.
be
expected.
AUCROC
(areaanalysis
under the
curve) andthe
specificity
compared
to theonly
calculation
forreduced
all data
employing
CCHFV values
seronegative
samples
revealed
ROCunder
analysis
the CCHFV
seronegative
samples
only revealed
reduced
AUC (area
the employing
curve) and specificity
values
compared to
the calculation
for all data
AUC (area under the curve) and specificity values compared to the calculation for all data
or for CCHFV seropositive samples, respectively (Table 3, Appendix A Figure A1). The
Viruses 2021, 13, 1398
7 of 13
Viruses 2021, 13, x FOR PEER REVIEW
7 of 13
inclusion of sera with CCHFV antibodies does not decrease the specificity of the DUGV
ELISA.
Hence,seropositive
these findings
further
support the
assumption
that the
performance
or for CCHFV
samples,
respectively
(Table
3, Appendix
A Figure
A1). Theof our
DUGV ELISA
is with
not negatively
influenced
bynot
thedecrease
presencethe
of specificity
CCHFV antibodies.
inclusion
of sera
CCHFV antibodies
does
of the DUGV
ELISA. Hence, these findings further support the assumption that the performance of our
Table
Comparative
ROC analysis.
DUGV3.ELISA
is not negatively
influenced by the presence of CCHFV antibodies.
Table 3. Comparative ROC analysis.
All Data
AUC
Specificity
AUC
Sensitivity
Specificity
Sensitivity
All
0.95Data
88.6%
0.95
95.8%
88.6%
95.8%
CCHFV
Seronegative
CCHFV
0.93
Seronegative
82.5%
0.93
97.8%
82.5%
97.8%
CCHFV
Seropositive
CCHFV
0.98
Seropositive
0.9894.6%
94.7%
94.6%
94.7%
Moreover, evaluation of cross-reactivity between CCHFV and DUGV was done with
Moreover, evaluation
of cross-reactivity
betweenand
CCHFV
and DUGV
was done
with
the generalized
linear model.
CCHFV seropositive
seronegative
samples
were
used as
the generalized linear model. CCHFV seropositive and seronegative samples were used
independent variables, and samples ID and the interaction of CCHFV and DUGV were set
as independent variables, and samples ID and the interaction of CCHFV and DUGV were
as random effects. There was no association between the seropositive and seronegative
set as random effects. There was no association between the seropositive and seronegative
CCHFV sera (p = 0.742) to detect antibodies against DUGV. Pearson’s Chi-squared test
CCHFV sera (p = 0.742) to detect antibodies against DUGV. Pearson’s Chi-squared test
showed that there is no statistically significant correlation between the CCHFV antibody
showed that there is no statistically significant correlation between the CCHFV antibody
status and DUGV antibody presence (p = 0.218). These results confirmed that there is no
status and DUGV antibody presence (p = 0.218). These results confirmed that there is no
statistically
significant difference between CCHFV seropositive and seronegative samples
statistically significant difference between CCHFV seropositive and seronegative samples
in
regards
to
DUGVantibody
antibodydetection.
detection.
in regards to DUGV
3.2. Validation of DUGV and CCHFV Immunofluorescence Assays
3.2. Validation of DUGV and CCHFV Immunofluorescence Assays
3.2.1. DUGV iIFA
3.2.1. DUGV iIFA
All cattle sera were analyzed with the DUGV iIFA (whole virus antigen). In Figure 5,
All cattle sera were analyzed with the DUGV iIFA (whole virus antigen). In Figure 5,
results for the corresponding sera of Table 4 are depicted. Detailed serological data for
results for the corresponding sera of Table 4 are depicted. Detailed serological data for
these
sera are available in Appendix A (Table A1). Not only DUGV antibody-positive sera
these sera are available in Appendix A (Table A1). Not only DUGV antibody-positive sera
led
to
E6E6
cells,
butbut
alsoalso
DUGV
antibody-negative
led to aaspecific
specificstaining
stainingofofDUGV-infected
DUGV-infectedVero
Vero
cells,
DUGV
antibodysera,
which
yielded
high
amounts
of
CCHFV
antibodies.
negative sera, which yielded high amounts of CCHFV antibodies.
Figure 5. DUGV IFA: Cells infected with DUGV (I), as well as non-infected control wells (II), are
Figure 5. DUGV IFA: Cells infected with DUGV (I), as well as non-infected control wells (II),
depicted. Sera A and B represent DUGV seropositive samples, with serum A being higher
are
depicted.
Sera
A and
B represent
samples,
serum
A being
seropositive
than
serum
B. Sera
C, D and EDUGV
yieldedseropositive
CCHFV antibodies
only.with
Whereas
serum
C is anhigher
seropositive
serum B.serum,
Sera C,sera
D and
E yielded
Whereas serum
example of a than
true-negative
D and
E showCCHFV
specific antibodies
staining of only.
DUGV-infected
cells. C is
Serum
F (CCHFV-/DUGV-)
served
as a negative
control.
an
example
of a true-negative
serum,
sera D and
E show specific staining of DUGV-infected cells.
Serum F (CCHFV−/DUGV−) served as a negative control.
Viruses 2021, 13, 1398
8 of 13
Table 4. Corresponding data to Figure 5.
A
(1077)
B
(1151)
C (568)
D (359)
E (642)
F (980)
DUGV ELISA
++
+
−
−
−
−
DUGV mVNT
++
+
−
−
−
−
IDVet ELISA
−
−
+
++
++
−
Vector−Best ELISA
−
−
+
++
++
−
In−house ELISA
−
−
++
+
++
−
Diagnostic Assay
DUGV
CCHFV
Diagnostic specificity, as well as the sensitivity of the DUGV iIFA, was calculated
based on the DUGV mVNT data as a gold standard. The fraction of false-positive sera in
the iIFA was 3-fold higher (18% vs. 6%) for CCHFV seropositive sera than for CCHFV
seronegative samples (Table 5). Diagnostic sensitivity was identical for both groups, but
diagnostic specificity was significantly lower (52% vs. 84%) for CCHFV seropositive sera
(Table 6).
Table 5. Comparison of DUGV iIFA and DUGV mVNT.
CCHFV seronegative samples
mVNT
iIFA
+
−
Total
+
58%
6%
64%
−
4%
32%
36%
Total
62%
38%
100%
CCHFV seropositive samples
mVNT
iIFA
+
−
Total
+
59%
18%
77%
−
3%
19%
23%
Total
63%
37%
100%
Table 6. Specificity and sensitivity of DUGV iIFA.
CCHFV
+
−
Total
Sensitivity
94%
95%
94%
Specificity
84%
52%
68%
3.2.2. CCHFV iIFA (Euroimmun)
A selection of Nigerian sera was tested with the species-adapted commercial CCHFV
iIFA (Euroimmun, Luebeck, Germany), as it has previously been observed that ruminant
sera following experimental DUGV immunizations, as well as infections, were crossreactive in this assay [20].
Figure 6 shows the results for the corresponding sera of Table 7 (detailed results are
provided in Appendix A, Table A2). Cattle sera that tested positive for DUGV antibodies
without the presence of CCHFV antibodies led to a highly specific staining of transfected
cells. This signal could not be discriminated from true positive CCHFV antisera.
Viruses 2021, 13, x FOR PEER REVIEW
9 of 13
Viruses 2021, 13, 1398
9 of 13
without the presence of CCHFV antibodies led to a highly specific staining of transfected
cells. This signal could not be discriminated from true positive CCHFV antisera.
Figure 6. CCHFV IFA (Euroimmun, Lübeck): Cells expressing CCHFV GPC (I) and non-transfected
Figure 6. CCHFV IFA (Euroimmun, Lübeck): Cells expressing CCHFV GPC (I) and non-transfected
control cells (II) are depicted. Serum A (CCHFV+/DUGV-) led to an undistinguishable fluorescent
controlcompared
cells (II) are
depicted.
A (CCHFV+/DUGV
to an undistinguishable
signal
to sera
B and Serum
C (CCHFV-/DUGV+).
Serum−)Dled
(CCHFV-/DUGV-)
served asfluorescent
the
signal
compared
to
sera
B
and
C
(CCHFV
−
/DUGV+).
Serum
D
(CCHFV
−
/DUGV
−) served as the
negative control.
negative control.
Table 7. Corresponding serological data to Figure 6.
Table 7. Corresponding serological data to Figure 6.
Diagnostic Assay
A (390)
DUGV
ELISA
Diagnostic Assay
A (390)DUGV
DUGV
mVNT
DUGV
ELISA
− DUGV
IDVet ELISA
++
DUGV mVNT
−
CCHFV
Vector-Best ELISA
++
IDVet ELISA
++
In-house ELISA
+
Vector−Best ELISA
++
CCHFV
4. Discussion
In-house ELISA
+
B (571)
++
B (571)
+ ++
+
−
−
C (526)
+ +(526)
C
++ +
+
−
−
D (497)
- D (497)
- −
−
−
−
−
−
−
DUGV and CCHFV, both members of the family Nairoviridae, are co-existing in
Nigeria
at present, as indicated by the serology data presented in this report. Serological
4. Discussion
assays for the detection of DUGV antibodies were established and validated utilizing 300
DUGV and CCHFV, both members of the family Nairoviridae, are co-existing in Nigeria
serum samples from Nigerian cattle. The major interest of this study was to investigate
at present, as indicated by the serology data presented in this report. Serological assays
whether the CCHFV antibody status has any influence on DUGV antibody detection and
for the detection of DUGV antibodies were established and validated utilizing 300 serum
vice versa.
samples from Nigerian cattle. The major interest of this study was to investigate whether
DUGV was first isolated in Nigeria [1] and was thereafter thought to be the most
the CCHFV antibody status has any influence on DUGV antibody detection and vice versa.
often isolated arbovirus there. However, the last reports were published in the 1970s [6–
first isolated
in were
Nigeria
[1] and in
was
thereafter
thought
to bepresent
the most
8,23]. DUGV
Aroundwas
50 years
later, we
interested
whether
DUGV
was still
in often
isolated
arbovirus
there.
However,
the
last
reports
were
published
in
the
1970s
[6–8,23].
Nigeria. Hence, we tested cattle sera for the presence of DUGV-specific antibodies as an
Around 50
later,
we were interested
whether
still present
in Nigeria.
indicator
foryears
DUGV
circulation.
Out of 300in sera,
187 DUGV
sampleswas
revealed
anti-DUGV
Hence,
we
tested
cattle
sera
for
the
presence
of
DUGV-specific
antibodies
as
an
indicator
antibodies by mVNT. Nearly two-thirds (62.3%) of the sampled cattle had a previous for
DUGVinfection
circulation.
Out and
of 300
187 samples
revealed
anti-DUGV
antibodies
by mVNT.
DUGV
history,
wesera,
consequently
assume
that DUGV
is still highly
prevalent
Nearly
two-thirds
(62.3%)
of
the
sampled
cattle
had
a
previous
DUGV
infection
history,
in Nigeria. Moreover, a substantial seroprevalence was also recorded for CCHFV
and
we
consequently
assume
that
DUGV
is
still
highly
prevalent
in
Nigeria.
Moreover,
(manuscript in preparation). In summary, both viruses are widely distributed in Nigeria,
a substantial
was
recorded
for CCHFV
(manuscript
in preparation).
and
therefore, seroprevalence
this sample panel
is also
suitable
for studying
the effects
of co-infection
and
In summary,
both viruses
are widely
distributed
in Moreover,
Nigeria, and
this be
sample
serological
cross-reactions
between
DUGV
and CCHFV.
boththerefore,
agents should
panelunder
is suitable
for studying
the effects
of co-infection
and
serological
cross-reactions
taken
consideration
as differential
diagnoses
for human
infections
and diseases
in
Nigeria.
can induce
a mild febrile
illness,should
but onebe
case
was under
documented
in
betweenDUGV
DUGV(BSL
and3)CCHFV.
Moreover,
both agents
taken
consideration
South
Africa with
more severe
clinical symptoms,
including
prolonged
thrombocytopenia
as differential
diagnoses
for human
infections and
diseases
in Nigeria.
DUGV (BSL 3) can
and
signsa of
hemorrhagic
fever. A
monospecific
rise documented
of anti-DUGVin
antibodies
without
the more
induce
mild
febrile illness,
but
one case was
South Africa
with
detection
of anti-CCHFV
to the assumption
that this and
disease
was
indeed
severe clinical
symptoms,antibodies
includingled
prolonged
thrombocytopenia
signs
of hemorrhagic
caused
DUGV [18]. rise
Theoffirst
confirmed
human CCHFV
in Nigeria
was
fever. Abymonospecific
anti-DUGV
antibodies
withoutinfection
the detection
of anti-CCHFV
antibodies led to the assumption that this disease was indeed caused by DUGV [18]. The
first confirmed human CCHFV infection in Nigeria was recorded in 2016 [16], implying
that this BSL 4 agent may lead to further human cases in the future or might have caused
undetected infections in the past. Therefore, the serological monitoring of animals (mainly
ruminants) can contribute to a risk assessment concerning human CCHFV (and DUGV)
Viruses 2021, 13, 1398
10 of 13
infections. As cross-reactivities between both agents have been reported, our main focus
was on the serological discrimination of these antibodies.
To validate the DUGV serological assays, the mVNT was set as a gold standard. All
sera were then analyzed with the DUGV ELISA, and iIFA, and diagnostic specificity and
sensitivity were calculated for each assay. Concerning the ELISA, ROC analysis revealed
95.7% sensitivity and 88.6% specificity for the determined cut-off value (40.9% of positive
control). All false -negative sera displayed only weak mVNT titers between 1/10 and 1/20.
The ELISA cut-off was significantly higher than the previously calculated cut-off employing
100 German cattle sera (mean + 3× standard deviation = 17.9%), underlining the need to
include African reference sera when establishing such serological assays. When comparing
corrected OD values for experimentally inoculated (DUGV strain: IBAR 1792) and naturally
infected cattle, the mean value for all Nigerian sera (encountering sera with corrected OD
values > 40.9%) was 174.1%, whereas four experimentally challenged animals only had
corrected OD values of 28.7%, 33.1%, 79.4% and 101.6%, respectively [20]. It appears that
there is no correlation between the CCHFV antibody presence and the DUGV ELISA results,
as the cross-tabulation and comparative ROC analyses did not reveal an interrelation. In
addition, the generalized linear model and Pearson Chi-squared calculations have not
shown a statistically significant association. In summary, the new DUGV ELISA is a
valuable tool for further serological investigations in demands of high-throughput testing
and can be used instead of the time-consuming and labor-intensive mVNT, which moreover
requires a BSL 3 facility.
All sera were also tested with the DUGV iIFA, and, in contrast to the results obtained
with the ELISA, significant cross-reactivities were observed for CCHFV seropositive samples. The amount of DUGV seronegative sera, which tested false-positive in the iIFA, was
3-fold increased for CCHFV seropositive sera than for seronegative. We, therefore, do
not recommend performing DUGV immunofluorescence assays. Moreover, a quarter of
iIFA false-positive sera were actually CCHFV-negative, probably due to previous other (orthonairo) virus infections, which may also interfere in this assay. We have shown recently
that antibodies to DUGV and Nairobi sheep disease orthonairovirus (NSDV) cross-react in
the iIFA, whereas the corresponding ELISAs detected the antibodies in a species-specific
way [24]. The investigation of cross-reactivities to Kupe orthonairovirus (KUPV) should be
part of future research.
The other way round, DUGV seropositive samples also led to positive results in
the species-adapted commercial CCHFV immunofluorescence assay. This was already
demonstrated for experimentally infected calves [20]. As only the GPC (glycoprotein
precursor) expressing cells led to positive results, cross-reactivities between DUGV and
CCHFV are most likely based on similar epitopes for the envelope glycoproteins. Therefore, these findings do not contradict our observations that N protein-based ELISAs can
reliably discriminate between DUGV and CCHFV antibodies. Serological cross-reactions
in immunofluorescence assays for orthonairoviruses have already been reported earlier [9].
In this study, only bovine sera were analyzed. However, it is likely that similar crossreactivities in immunofluorescence assays also apply for other animal sera (e.g., ovine,
caprine) or even human sera. This pertains not only to Nigeria but also to further African
countries, where both viruses co-exist.
Concerning cross-neutralizing epitopes, the neutralizing potential of CCHFV antibodies for DUGV was included in this study. Six sera (out of 60 CCHFV seropositive sera below
the DUGV ELISA cut-off) displayed weak mVNT titers. These findings do not support
the presence of cross-neutralizing antibodies, as CCHFV seronegative samples (2 out of
49) also revealed DUGV neutralizing antibodies with negative results in the DUGV ELISA.
Therefore, we assume that the CCHFV immune status does not influence the susceptibility
to a consequent DUGV infection; this will probably also be true vice versa. However, it
cannot be fully excluded that there might be an influence on the pathogenesis during a following heterologous infection, e.g., a shorter viremic state due to a faster immune response,
particularly if cross-reactivities between the glycoproteins are presumed (see CCHFV iIFA
Viruses 2021, 13, 1398
11 of 13
results), which are actually thought to be the target for neutralizing antibodies [25,26].
Nevertheless, this hypothesis should be neglected as even homologous reinfections with
CCHFV have been documented [27–29].
Furthermore, the neutralizing antibodies in DUGV-ELISA negative sera might be the
result of earlier infections with other orthonairoviruses. Recently, we have shown that
NSDV antisera can also lead to weak positive results in the DUGV mVNT. However, NSDV
has not been isolated in Nigeria yet, and therefore, we assume that the DUGV mVNT
is still a reliable gold standard for the detection of DUGV antibodies [24]. The impact
of cross-neutralizing antibodies on KUPV has not been investigated so far. In parallel,
increased sensitivity of the DUGV mVNT in comparison to the novel DUGV ELISA might
be another suitable explanation for the eight false-negative serum samples. Indeed, recent
studies have revealed that neutralization assays were slightly more sensitive than ELISAs
for the detection of DUGV and NSDV antibodies [24].
In conclusion, the ELISA and mVNT results clearly emphasize the co-circulation of
DUGV and CCHFV, rather than cross-reactions between the two viruses, in Nigerian cattle.
Author Contributions: Conceptualization, M.H.G., D.O. and J.H.; methodology, J.H. and O.B.D.;
formal analysis, J.H. and B.S.; investigation, J.H. and O.B.D.; data curation, J.H. and O.B.D.; writing—
original draft preparation, J.H.; writing—review and editing, O.B.D., J.O., M.K., D.O. and M.H.G.;
visualization, J.H.; supervision, D.O., M.K. and M.H.G.; project administration, M.H.G. and J.O.;
funding acquisition, M.H.G. and J.O. All authors have read and agreed to the published version of
the manuscript.
Funding: This research was partially co-funded by the EU commission through the VetBioNet (grant
no. 731014), ERANET LEAP-AGRI (grant designation LEARN) and CCHFVaccine (grant no. 732732)
projects, as well as by the Alexander-von-Humboldt-Stiftung.
Institutional Review Board Statement: Human samples were not used in this study. Animal sera
were collected as approved by the Animal Care and Use Research Ethics Committee (ACUREC),
University of Ibadan, Ibadan, Nigeria (UI-ACUREC/18/0143).
Informed Consent Statement: Not applicable.
Data Availability Statement: The data presented in this study are available within this manuscript,
Hartlaub et al., Viruses.
Acknowledgments: We thank Katrin Schwabe, Martina Abs and René Schöttner for excellent technical assistance.
Conflicts of Interest: The authors declare no conflict of interest.
Viruses 2021, 13, x FOR PEER REVIEW
12 of 13
Appendix A
Figure A1.
A1. Comparative
analyses:
Graph
(a) shows
the ROC
all 300
Figure
ComparativeROC
ROC
analyses:
Graph
(a) shows
the curve
ROC for
curve
for serum
all 300samples,
serum samgraph (b) the 150 CCHFV seronegative samples and graph (c) the 150 CCHFV seropositive samples
ples, graph (b) the 150 CCHFV seronegative samples and graph (c) the 150 CCHFV seropositive
only.
samples only.
Table A1. Detailed version of Table 4 in the main section.
Diagnostic Assay
DUGV ELISA
unit A (1077)
S/P%
293%
B
C (568) D (359) E (642) F (980)
(1151)
103%
13%
0%
12%
19%
Viruses 2021, 13, 1398
12 of 13
Table A1. Detailed version of Table 4 in the main section.
Diagnostic Assay
DUGV
CCHFV
unit
A (1077)
B
(1151)
C (568)
D (359)
E (642)
F (980)
DUGV ELISA
S/P%
293%
103%
13%
0%
12%
19%
DUGV mVNT
ND50
321
57
<10
<10
<10
<10
IDVet ELISA
S/P%
7%
10%
119%
201%
235%
8%
Vector-Best ELISA
OD
0.29
0.21
1.27
1.81
2.55
0.4
In-house ELISA
S/P%
16%
8%
155%
97%
133%
−8%
S/P%: sample to positive ratio, ND50 : 50% neutralization dose, OD: optical density.
Table A2. Detailed version of Table 7 in the main section.
Diagnostic Assay
DUGV
CCHFV
Unit
A (390)
B (571)
C (526)
D (497)
DUGV ELISA
S/P%
−9%
265%
262%
−9%
DUGV mVNT
ND50
<10
57
57
<10
IDVet ELISA
S/P%
196%
5%
9%
4%
Vector-Best ELISA
OD
1.64
0.31
0.22
0.31
In-house ELISA
S/P%
22%
10%
7%
4%
S/P%: sample to positive ratio, ND50 : 50% neutralization dose, OD: optical density.
References
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
Causey, O.R.; Kemp, G.E.; Casals, J.; Williams, R.W.; Madbouly, M.H. Dugbe Virus, A New Arbovirus from Nigeria. Niger. J. Sci.
1971, 5, 41–43.
Wood, O.L.; Lee, V.H.; Ash, J.S.; Casals, J. Crimean-congo hemorrhagic fever, Thogoto, dugbe, and Jos viruses isolated from
ixodid ticks in Ethiopia. Am. J. Trop. Med. Hyg. 1978, 27, 600–604. [CrossRef] [PubMed]
Tomori, O.; Monath, T.P.; O’Connor, E.H.; Lee, V.H.; Cropp, C.B. Arbovirus infections among laboratory personnel in Ibadan,
Nigeria. Am. J. Trop. Med. Hyg. 1981, 30, 855–861. [CrossRef] [PubMed]
Moore, D.L.; Causey, O.R.; Carey, D.E.; Reddy, S.; Cooke, A.R.; Akinkugbe, F.M.; David-West, T.S.; Kemp, G.E. Arthropod-borne
viral infections of man in Nigeria, 1964–1970. Ann. Trop Med. Parasitol. 1975, 69, 49–64. [CrossRef]
David-West, T.S.; Cooke, A.R.; David-West, A.S. A serological survey of Dugbe virus antibodies in Nigerians. Trans. R. Soc. Trop.
Med. Hyg. 1975, 69, 358. [CrossRef]
Kemp, G.E.; Causey, O.R.; Setzer, H.W.; Moore, D.L. Isolation of viruses from wild mammals in West Africa, 1966–1970. J. Wildl.
Dis. 1974, 10, 279–293. [CrossRef]
Williams, R.W.; Causey, O.R.; Kemp, G.E. Ixodid ticks from domestic livestock in Ibadan, Nigeria as carriers of viral agents. J.
Med. Entomol. 1972, 9, 443–445. [CrossRef]
Kemp, G.E.; Causey, O.R.; Moore, D.L.; O’Connor, E.H. Viral isolates from livestock in northern Nigeria: 1966–1970. Am. J. Vet.
Res. 1973, 34, 707–710.
Casals, J.; Tignor, G.H. The Nairovirus genus: Serological relationships. Intervirology 1980, 14, 144–147. [CrossRef] [PubMed]
Davies, F.G.; Casals, J.; Jesset, D.M.; Ochieng, P. The serological relationships of Nairobi sheep disease virus. J. Comp. Pathol. 1978,
88, 519–523. [CrossRef]
Honig, J.E.; Osborne, J.C.; Nichol, S.T. The high genetic variation of viruses of the genus Nairovirus reflects the diversity of their
predominant tick hosts. Virology 2004, 318, 10–16. [CrossRef]
Marczinke, B.I.; Nichol, S.T. Nairobi sheep disease virus, an important tick-borne pathogen of sheep and goats in Africa, is also
present in Asia. Virology 2002, 303, 146–151. [CrossRef] [PubMed]
WHO. R&D Blueprint List of Priority Diseases. Available online: https://www.who.int/activities/prioritizing-diseases-forresearch-and-development-in-emergency-contexts (accessed on 9 March 2021).
Spengler, J.R.; Bergeron, E.; Rollin, P.E. Seroepidemiological Studies of Crimean-Congo Hemorrhagic Fever Virus in Domestic
and Wild Animals. PLoS Negl. Trop. Dis. 2016, 10, e0004210. [CrossRef] [PubMed]
Oluwayelu, D.; Afrough, B.; Adebiyi, A.; Varghese, A.; Eun-Sil, P.; Fukushi, S.; Yoshikawa, T.; Saijo, M.; Neumann, E.; Morikawa,
S.; et al. Prevalence of Antibodies to Crimean-Congo Hemorrhagic Fever Virus in Ruminants, Nigeria, 2015. Emerg. Infect. Dis.
2020, 26, 744–747. [CrossRef]
Bukbuk, D.N.; Dowall, S.D.; Lewandowski, K.; Bosworth, A.; Baba, S.S.; Varghese, A.; Watson, R.J.; Bell, A.; Atkinson, B.; Hewson,
R. Serological and Virological Evidence of Crimean-Congo Haemorrhagic Fever Virus Circulation in the Human Population of
Borno State, Northeastern Nigeria. PLoS Negl. Trop. Dis. 2016, 10, e0005126. [CrossRef]
Guilherme, J.M.; Gonella-Legall, C.; Legall, F.; Nakoume, E.; Vincent, J. Seroprevalence of five arboviruses in Zebu cattle in the
Central African Republic. Trans. R. Soc. Trop. Med. Hyg. 1996, 90, 31–33. [CrossRef]
Viruses 2021, 13, 1398
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
13 of 13
Burt, F.J.; Spencer, D.C.; Leman, P.A.; Patterson, B.; Swanepoel, R. Investigation of tick-borne viruses as pathogens of humans in
South Africa and evidence of Dugbe virus infection in a patient with prolonged thrombocytopenia. Epidemiol. Infect. 1996, 116,
353–361. [CrossRef] [PubMed]
Ward, V.K.; Marriott, A.C.; Polyzoni, T.; el-Ghorr, A.A.; Antoniadis, A.; Nuttall, P.A. Expression of the nucleocapsid protein of
Dugbe virus and antigenic cross-reactions with other nairoviruses. Virus Res. 1992, 24, 223–229. [CrossRef]
Hartlaub, J.; von Arnim, F.; Fast, C.; Mirazimi, A.; Keller, M.; Groschup, M.H. Experimental Challenge of Sheep and Cattle with
Dugbe Orthonairovirus, a Neglected African Arbovirus Distantly Related to CCHFV. Viruses 2021, 13, 372. [CrossRef]
Mertens, M.; Vatansever, Z.; Mrenoshki, S.; Krstevski, K.; Stefanovska, J.; Djadjovski, I.; Cvetkovikj, I.; Farkas, R.; Schuster, I.;
Donnet, F.; et al. Circulation of Crimean-Congo Hemorrhagic Fever Virus in the former Yugoslav Republic of Macedonia revealed
by screening of cattle sera using a novel enzyme-linked immunosorbent assay. PLoS Negl. Trop. Dis. 2015, 9, e0003519. [CrossRef]
Maiga, O.; Sas, M.A.; Rosenke, K.; Kamissoko, B.; Mertens, M.; Sogoba, N.; Traore, A.; Sangare, M.; Niang, M.; Schwan, T.G.; et al.
Serosurvey of Crimean-Congo Hemorrhagic Fever Virus in Cattle, Mali, West Africa. Am. J. Trop. Med. Hyg. 2017, 96, 1341–1345.
[CrossRef]
Kemp, G.E.; Causey, O.R.; Causey, C.E. Virus isolations from trade cattle, sheep, goats and swine at Ibadan, Nigeria, 1964–1968.
Bull. Epizoot Dis. Afr. 1971, 19, 131–135.
Hartlaub, J.; Keller, M.; Groschup, M.H. Deciphering Antibody Responses to Orthonairoviruses in Ruminants. Microorganisms
2021, 9, 1493. [CrossRef]
Buttigieg, K.R.; Dowall, S.D.; Findlay-Wilson, S.; Miloszewska, A.; Rayner, E.; Hewson, R.; Carroll, M.W. A novel vaccine against
Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model. PLoS ONE 2014, 9,
e91516. [CrossRef] [PubMed]
Zivcec, M.; Guerrero, L.I.W.; Albarino, C.G.; Bergeron, E.; Nichol, S.T.; Spiropoulou, C.F. Identification of broadly neutralizing
monoclonal antibodies against Crimean-Congo hemorrhagic fever virus. Antivir. Res. 2017, 146, 112–120. [CrossRef]
Gonzalez, J.P.; Camicas, J.L.; Cornet, J.P.; Wilson, M.L. Biological and clinical responses of west African sheep to Crimean-Congo
haemorrhagic fever virus experimental infection. Res. Virol. 1998, 149, 445–455. [CrossRef]
Burt, F.S.; Swanepoel, R.; Braack, L. Enzyme-linked immunosorbent assays for the detection of antibody to Crimean-Congo
haemorrhagic fever virus in the sera of livestock and wild vertebrates. Epidemiol. Infect. 1993, 111, 547–557. [CrossRef] [PubMed]
Wilson, M.L.; Gonzalez, J.P.; Cornet, J.P.; Camicas, J.L. Transmission of Crimean-Congo haemorrhagic fever virus from experimentally infected sheep to Hyalomma truncatum ticks. Res. Virol. 1991, 142, 395–404. [CrossRef]